Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of aGVHD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03715868
What this trial is testing

Pre-operative Short-term Administration of a Formula Diet Containing a Non-milk-derived Protein Source for Prevention of Acute Kidney Injury After Cardiac Surgery

Who this might be right for
Acute Renal FailureAcute Kidney Injury
University of Cologne 117
Post-approval studies (Phase 4)Study completedNCT03301155
What this trial is testing

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

Who this might be right for
Preventive Medicine
Materia Medica Holding 1,036
Not applicableEnded earlyNCT03465735
What this trial is testing

Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

Who this might be right for
Acute DVT of Lower Extremity
Mayo Clinic 15
Testing effectiveness (Phase 2)UnknownNCT06270225
What this trial is testing

SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.

Who this might be right for
Gout Arthritis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 157
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Post-approval studies (Phase 4)Looking for participantsNCT06792214
What this trial is testing

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
Mount Sinai Hospital, Canada 118
Testing effectiveness (Phase 2)Ended earlyNCT02737306
What this trial is testing

Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation

Who this might be right for
Graft Vs Host Disease
CytoDyn, Inc. 11
Not applicableWithdrawnNCT04071743
What this trial is testing

Study of Gammacore Sapphire for the Acute and Preventive Treatment of Post-Traumatic Headache (GAP-PTH)

Who this might be right for
Post-Traumatic Headache
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06904482
What this trial is testing

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Who this might be right for
aGVHDAcute Myelogenous LeukemiaAcute Lymphocytic Leukemia+1 more
Case Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT07256210
What this trial is testing

Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Not applicableStudy completedNCT02641886
What this trial is testing

The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction

Who this might be right for
Cognitive Impairment
Dongfang Hospital Beijing University of Chinese Medicine 300
Testing effectiveness (Phase 2)Looking for participantsNCT04935684
What this trial is testing

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative Syndrome+4 more
University Hospital, Clermont-Ferrand 150
Post-approval studies (Phase 4)Study completedNCT00304447
What this trial is testing

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Who this might be right for
Leukemia, Myelocytic, AcuteInfusions, Intravenous
Wyeth is now a wholly owned subsidiary of Pfizer 30
Testing effectiveness (Phase 2)UnknownNCT05858814
What this trial is testing

RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia
Guangdong Ruishun Biotech Co., Ltd 72
Not applicableUnknownNCT05622292
What this trial is testing

The Effectivity of the Mobile App "HARKIT I-Care" in Secondary Prevention in Post-ACS Patients

Who this might be right for
Acute Coronary Syndrome
National Cardiovascular Center Harapan Kita Hospital Indonesia 60
Not applicableStudy completedNCT04490200
What this trial is testing

Effectiveness of a Novel Respirator With Chitosan Nanoparticles

Who this might be right for
Covid19SARS-CoV InfectionWorker-Patient Transmission, Healthcare
University of Brasilia 300
Large-scale testing (Phase 3)Study completedNCT04346693
What this trial is testing

An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19

Who this might be right for
Acute Respiratory Tract InfectionAcute Respiratory InsufficiencyPneumonia+2 more
Burnasyan Federal Medical Biophysical Center 320
Not applicableStudy completedNCT04885452
What this trial is testing

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Who this might be right for
SARS-CoV InfectionCovid19
ANRS, Emerging Infectious Diseases 756
Not applicableLooking for participantsNCT07187947
What this trial is testing

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Who this might be right for
Gender IncongruenceCardiovascular (CV) RiskCardiovascular Disease Risk Factor+4 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500
Next Page